IL6 and chronic kidney disease: To date, there has been no data on the effect of IL-6 polymorphisms and IL-6 levels on the risk of atherosclerotic cardiovascular disease (ASCVD) and cardiovascular mortality in CKD patients, especially in Javanese ethnicity, the largest ethnic group in Indonesia.